EA
MRK icon

Eclectic Associates’s Merck MRK Stock Holding History

Eclectic Associates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,966
Closed -$337K – 120
2024
Q3 		$337K Buy
2,966
+67
+2% +$7.96K 0.13% 82
2024
Q2 		$359K Buy
2,899
+40
+1% +$5.15K 0.16% 68
2024
Q1 		$377K Sell
2,859
-128
-4% -$15.8K 0.17% 65
2023
Q4 		$326K Buy
+2,987
New +$310K 0.16% 63
2023
Q3 		– Sell
-2,017
Closed -$233K – 85
2023
Q2 		$233K Sell
2,017
-281
-12% -$31.9K 0.11% 73
2023
Q1 		$244K Sell
2,298
-11
-0.5% -$1.19K 0.13% 71
2022
Q4 		$256K Buy
+2,309
New +$236K 0.12% 67
2022
Q3 		– Sell
-2,209
Closed -$201K – 66
2022
Q2 		$201K Buy
+2,209
New +$196K 0.14% 66

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Eclectic Associates's MRK Position: Q4 2024 in Review

Eclectic Associates sold out of Merck (MRK) in Q4 2024, closing a stake of 2,966 shares — an estimated $337K sold.

Eclectic Associates first reported a position in MRK in Q2 2022 and held it in 8 quarters. The position peaked at $377K in Q1 2024. 3,608 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Eclectic Associates reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • Eclectic Associates sold 2,966 Merck shares in Q4 2024, an estimated $337K.
  • Eclectic Associates first reported a position in Merck in Q2 2022 and held it in 8 quarters.
  • Eclectic Associates's Merck position peaked at $377K in Q1 2024.
  • 3,608 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Eclectic Associates's 13F filing for Q4 2024, filed 21 Jan 2025.